Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.42 - $0.72 $4,316 - $7,399
10,277 Added 3.25%
326,775 $205,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.73 $12,697 - $28,886
-10,581 Reduced 3.23%
316,498 $427,000
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $63,210 - $133,443
36,965 Added 12.74%
327,079 $608,000
Q2 2022

Aug 15, 2022

BUY
$2.13 - $9.01 $617,942 - $2.61 Million
290,114 New
290,114 $708,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Mic Capital Management Uk LLP Portfolio

Follow Mic Capital Management Uk LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mic Capital Management Uk LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mic Capital Management Uk LLP with notifications on news.